基于超声剪切波弹性成像参数与临床风险因素的术后胰瘘改良预测模型
田晓梵, 董怡, 楼文晖, 张琪, 邱艺杰, 左丹, 王文平

A modified clinically relevant post-operative pancreatic fistula risk evaluation model based on ultrasound shear wave elastography: a prospective study
TIAN Xiaofan, DONG Yi, LOU Wenhui, ZHANG Qi, QIU Yijie, ZUO Dan, WANG Wenping
表1 CR-POPF阳性和阴性的胰腺肿瘤患者临床特征的比较
Tab 1 Comparison of clinical characteristics between CR-POPF-positive and -negative pancreatic tumor patients
IndexCR-POPF positive (n=35)CR-POPF negative (n=65)t/χ2 valueP value
Gender/n(%)0.3960.529
Male16 (45.7)34 (52.3)
Female19 (54.3)31 (47.7)
Age/year57.7±14.460.1±12.50.8870.378
BMI/(kg·m-2)23.5±2.923.1±3.3-0.7020.484
γ-GT>150 U·L-1/n(%)4 (11.4)16 (24.6)2.4730.116
TAG>1.7 mmol·L-1/n(%)10 (28.6)18 (27.7)0.0090.926
Cholesterol>5.2 mmol·L-1/n(%)6 (17.1)12 (18.5)0.0270.870
Diabetes mellitus/n(%)4 (11.4)16 (24.6)2.4730.116
Lesion size/mm29.6±14.829.8±14.10.0810.935
MPD diameter≤3 mm/n(%)29 (82.9)36 (55.4)7.5470.006
SWV value/(m·s-1)
Pancreatic parenchyma0.86±0.181.24±0.455.9410.000
Lesion1.42±0.601.41±0.64-0.0780.938
Lesion-parenchyma ratio1.69±0.721.24±0.68-3.0440.003
Surgery type/n(%)1.2930.256
Pancreaticoduodenectomy9 (25.7)24 (36.9)
Distal pancreatectomy26 (74.3)41 (63.1)
Surgery duration/min178.3±66.7195.7±80.61.0910.278
Blood loss/mL138.3±131.0119.2±139.8-0.6640.508
Palpation of pancreas/n(%)1.8760.171
Soft19 (54.3)26 (40.0)
Medium-hard16 (45.7)39 (60.0)
Pathological diagnosis of PDAC/PASC/n(%)13 (37.1)37 (56.9)3.5600.059
FRS/point4.9±1.33.8±1.8-2.8910.005
a-FRS/%60.6±27.221.3±23.2-7.5930.000